Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes Results from the DCCT/EDIC study

被引:68
作者
Martin, Catherine L. [1 ]
Waberski, Barbara H. [2 ]
Pop-Busui, Rodica [1 ]
Cleary, Patricia A. [2 ]
Catton, Sarah [3 ]
Albers, James W. [1 ]
Feldman, Eva L. [1 ]
Herman, William H. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] George Washington Univ, Ctr Biostat, Rockville, MD USA
[3] Univ Washington, Med Ctr, Seattle, WA 98195 USA
关键词
NEUROTHESIOMETER; DIAGNOSIS;
D O I
10.2337/dc10-0616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To describe the sensitivity specificity positive predictive value and negative predictive value of vibration perception threshold (VPT) testing in subjects with type 1 diabetes relative to gold standard assessments of peripheral neuropathy RESEARCH DESIGN AND METHODS - VPT was determined in 1 177 adults with type 1 diabetes 13-14 years after participating in a study of intensive (INT) versus conventional (CONV) diabetes treatment Abnormal VPT was defined by values exceeding 2 5 SD above age specific normal values Signs and symptoms of peripheral neuropathy were assessed and electrodiagnostic studies were performed to establish definite clinical neuropathy abnormal nerve conduction and confirmed clinical neuropathy (the presence of both definite clinical neuropathy and abnormal nerve conduction) RESULTS - Thirty seven percent of subjects had definite clinical neuropathy 61% had abnormal nerve conduction and 30% had confirmed clinical neuropathy Abnormal VPT was more common among former CONV than among INT subjects (64 vs 57% P < 0 05) and was associated with older age VPT was a sensitive measure of confirmed clinical neuropathy (87%) and of definite clinical neuropathy (80%) and a specific measure of abnormal nerve conduction (62%) Higher VPT cut points improved test sensitivity and lower cut points improved specificity Areas under the receiver operating characteristic curves ranged from 0 71-0 83 and were higher for older than for younger subjects and highest for those with confirmed clinical neuropathy CONCLUSIONS - VPT was a sensitive measure of peripheral neuropathy Future researchers may choose to select VPT cut points for defining abnormality based on the population studied and clinical outcome of interest
引用
收藏
页码:2635 / 2641
页数:7
相关论文
共 24 条
[1]   Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion [J].
Albers, James W. ;
Herman, William H. ;
Pop-Busui, Rodica ;
Martin, Catherine L. ;
Cleary, Patricia ;
Waberski, Barbara .
DIABETES CARE, 2007, 30 (10) :2613-2618
[2]   Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study [J].
Albers, James W. ;
Herman, William H. ;
Pop-Busui, Rodica ;
Feldman, Eva L. ;
Martin, Catherine L. ;
Cleary, Patricia A. ;
Waberski, Barbara H. ;
Lachin, John M. .
DIABETES CARE, 2010, 33 (05) :1090-1096
[3]   Technology literature review: Quantitative sensory testing [J].
Chong P.S.T. ;
Cros D.P. .
MUSCLE & NERVE, 2004, 29 (05) :734-747
[4]  
[Anonymous], 1988, DIABETES, V37, P1000
[6]  
[Anonymous], 1992, NEUROLOGY, V42, P1823
[7]  
[Anonymous], 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
[8]  
[Anonymous], ANN NEUROL
[9]  
[Anonymous], QUANTITATIVE SENSORY
[10]   Diabetic neuropathies - A statement by the American Diabetes Association [J].
Boulton, AJM ;
Vinik, AI ;
Arezzo, JC ;
Bril, V ;
Feldman, EL ;
Freeman, R ;
Malik, RA ;
Maser, RE ;
Sosenko, JM ;
Ziegler, D .
DIABETES CARE, 2005, 28 (04) :956-962